Inventor · disambiguated record
Christian Eeckhout
Also filed as: EECKHOUT CHRISTIAN
9 granted patents·127 citations·filing 1992–2002
88Inventor score
Top patents by PatentIndex Score
9 records- 0181US6300336B1Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tracts, particularly abdominal visceral pain which accompanies themSOLVAY PHARM GMBH·Filed 2000·Granted Oct 9, 2001·18 cites·4 claims
- 0273US6165985A11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising themSOLVAY PHARM GMBH·Filed 1999·Granted Dec 26, 2000·33 cites·14 claims
- 0372US6407106B1N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activitySOLVAY PHARM GMBH·Filed 2001·Granted Jun 18, 2002·7 cites·8 claims
- 0468US5418224A4,13-dioxabicyclo[8.2.1]tridecenone compounds and pharmaceutical compositions containing themKALI CHEMIE PHARMA GMBH·Filed 1992·Granted May 23, 1995·22 cites·2 claims
- 0564US6770649B21-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2002·Granted Aug 3, 2004·2 cites·12 claims
- 0664US5912235A10, 13, 15-trioxatricyclo 9.2.1.1.9.6 !-pentadecan one derivatives, method for their production and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 1997·Granted Jun 15, 1999·23 cites·8 claims
- 0757US5438068AMethod of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compoundsKALI CHEMIE PHARMA GMBH·Filed 1993·Granted Aug 1, 1995·12 cites·11 claims
- 0852US6001833AUrea derivativesSOLVAY PHARM GMBH·Filed 1998·Granted Dec 14, 1999·10 cites·5 claims
- 0929US6040303A7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 1998·Granted Mar 21, 2000·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Christian Eeckhout files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →